India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback